Beauty Farm Medical and Health Industry Inc. will convene its annual general meeting on 26 June 2026 at 9:30 a.m. in Central, Hong Kong. Shareholders will be asked to approve the 2025 audited financial statements, vote on the re-election of five directors, and authorise the board to set directors’ remuneration.

The board is recommending a final dividend of HK$0.72 per share for the financial year ended 31 December 2025. If approved, the share register will close from 21 August 2026 to 27 August 2026, with 27 August 2026 set as the record date for dividend entitlement.

Directorate changes up for approval include the re-election of Executive Director and Vice Chairman Lian Songyong, Non-executive Directors Li Fangyu, Gao Jianming and Yi Lin, and Independent Non-executive Director Liu Teng. Shareholders will also vote on re-appointing PricewaterhouseCoopers as the Company’s auditor and authorising the board to determine its remuneration.

The meeting will consider granting a general mandate allowing the board to repurchase up to 10% of the Company’s issued shares and a separate mandate to issue new shares or transfer treasury shares up to 20% of the existing share capital, with an additional uplift of up to 10% corresponding to any shares repurchased. A special resolution seeks approval to adopt the Third Amended and Restated Memorandum and Articles of Association.

For voting rights at the AGM, the share register will be closed from 23 June 2026 to 26 June 2026, and the record date is set for 26 June 2026. Valid proxy forms must reach Computershare Hong Kong Investor Services by 9:30 a.m. on 24 June 2026.